Items tagged “prostate malignancy”

9 results found
Article

Prostate cancer

Prostate cancer ranks as the most common primary malignant tumor in men and the second most common cause of cancer-related deaths in men. Prostatic adenocarcinoma is by far the most common histological type and is the primary focus of this article. Epidemiology It is primarily a disease of the...
Case

Prostate-seminal vesicle angle (TRUS)

  Diagnosis not applicable
Gustavo Graco
Published 12 May 2020
60% complete
Annotated image
Case

Metastasis on routine lumbar spine MRI

  Diagnosis certain
Bassem Marghany
Published 02 Sep 2019
92% complete
CT MRI
Case

Prostate cancer (multiparametric MRI)

  Diagnosis certain
Bassem Marghany
Published 04 Sep 2019
95% complete
MRI
Case

Prostatic rhabdomyosarcoma

  Diagnosis certain
Ashesh Ishwarlal Ranchod
Published 04 Feb 2023
95% complete
Pathology MRI Ultrasound
Article

PSMA theranostics

PSMA theranostics is an emerging nuclear medicine approach in the management of prostate cancer that combines the use of prostate-specific membrane antigen (PSMA)-targeted imaging and therapy 1. PSMA-targeted imaging can be used to identify and locate prostate cancer cells, while PSMA radioligan...
Case

Sarcoid-like reaction

  Diagnosis almost certain
Osmay Cardoso
Published 06 Jul 2023
82% complete
Nuclear medicine
Case

Osteoblastic metastases - prostatic carcinoma

  Diagnosis certain
Ashesh Ishwarlal Ranchod
Published 24 Jun 2023
94% complete
X-ray
Article

Lutetium-177 vipivotide tetraxetan

Lutetium-177 vipivotide tetraxetan, trade name Pluvicto, also known as 177Lu-PSMA-617, is a theranostic (i.e. both therapeutic and diagnostic) agent approved as a treatment for adult patients with treatment-resistant advanced metastatic prostate cancer.  The treatment works by binding to cancer ...